Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 211961
Company: ACCORD HLTHCARE
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
DAPTOMYCIN DAPTOMYCIN 500MG/VIAL POWDER;INTRAVENOUS Prescription AP No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
06/24/2019 ORIG-1 Approval STANDARD

Label is not available on this site.

DAPTOMYCIN

POWDER;INTRAVENOUS; 500MG/VIAL
TE Code = AP

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CUBICIN DAPTOMYCIN 500MG/VIAL POWDER;INTRAVENOUS Prescription Yes AP 021572 CUBIST PHARMS LLC
DAPTOMYCIN DAPTOMYCIN 500MG/VIAL POWDER;INTRAVENOUS Prescription No AP 211961 ACCORD HLTHCARE
DAPTOMYCIN DAPTOMYCIN 500MG/VIAL POWDER;INTRAVENOUS Prescription No AP 212513 BE PHARMS
DAPTOMYCIN DAPTOMYCIN 500MG/VIAL POWDER;INTRAVENOUS Prescription No AP 208375 DR REDDYS
DAPTOMYCIN DAPTOMYCIN 500MG/VIAL POWDER;INTRAVENOUS Prescription No AP 206077 FRESENIUS KABI USA
DAPTOMYCIN DAPTOMYCIN 500MG/VIAL POWDER;INTRAVENOUS Prescription No AP 202857 HOSPIRA INC
DAPTOMYCIN DAPTOMYCIN 500MG/VIAL POWDER;INTRAVENOUS Prescription No AP 212022 JIANGSU HENGRUI MED
DAPTOMYCIN DAPTOMYCIN 500MG/VIAL POWDER;INTRAVENOUS Prescription No AP 205037 MYLAN LABS LTD
DAPTOMYCIN DAPTOMYCIN 500MG/VIAL POWDER;INTRAVENOUS Prescription No AP 091039 TEVA PHARMS USA
DAPTOMYCIN DAPTOMYCIN 500MG/VIAL POWDER;INTRAVENOUS Prescription No AP 206005 XELLIA PHARMS APS

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English